CTOs on the Move

OncoGenex

www.OncoGenex.com

 
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Eksigent Technologies

Eksigent Technologies is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biomedical International

Biomedical International is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Medical Development Inc

National Medical Development Inc is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SouthLight Healthcare

SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...

United States Post Acute

US Post Acute Care is a Management Services Organization providing value-added service to clinical practice groups specializing in the care of patients in the post-acute setting. An organization with a national footprint, US Post Acute Care provides a full array of management services including billing, recruiting, training, compliance, analytics, and practice development. US Post Acute Care structures its services offering both to serve the needs as well as leverage the capabilities of its clinicians: the physicians and advanced practitioners dedicated to improving the quality of care for their patients. US Post Acute Care has designed and launched a proprietary clinical excellence program called SmartPAC™, a comprehensive clinical program for post-acute care designed to enable practitioners to improve patient outcomes with better quality care. Please